Canaccord Genuity Maintains a 'Buy' on DexCom (DXCM); Gen 4 in FDA's Hands Now
Go back to Canaccord Genuity Maintains a 'Buy' on DexCom (DXCM); Gen 4 in FDA's Hands Now| DexCom, Inc. (NASDAQ: DXCM) | Delayed: 92.34 +2.12 (2.35%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $90.22 | 52 Week High | $96.38 | |||
| Open | $89.61 | 52 Week Low | $47.92 | |||
| Day High | $92.56 | P/E | N/A | |||
| Day Low | $89.20 | EPS | $-0.42 | |||
| Volume | 3,481,500 | |||||
